Vanguard Group Inc Forte Biosciences, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 14, 2024	BUY	$0.38 - $0.82 $152 - $328	400 Added 0.06%	665,230 $545,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.11 $16,936 - $19,183	17,282 Added 2.67%	664,830 $691,000
Q4 2022 Feb 10, 2023	BUY	$0.96 - $28.0 $244 - $7,140	255 Added 0.04%	647,548 $647,000
Q3 2022 Nov 14, 2022	BUY	$1.06 - $27.75 $197,328 - $5.17 Million	186,159 Added 40.37%	647,293 $692,000
Q2 2022 Aug 12, 2022	BUY	$1.07 - $1.55 $258,994 - $375,179	242,051 Added 110.48%	461,134 $599,000
Q1 2022 May 13, 2022	SELL	$1.21 - $2.24 $366,686 - $678,825	-303,047 Reduced 58.04%	219,083 $320,000
Q4 2021 Feb 14, 2022	SELL	$2.02 - $3.36 $74,148 - $123,335	-36,707 Reduced 6.57%	522,130 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$2.96 - $36.67 $95,664 - $1.19 Million	32,319 Added 6.14%	558,837 $1.65 Million
Q2 2021 Aug 13, 2021	BUY	$31.5 - $42.5 $16.6 Million - $22.4 Million	526,518 New	526,518 $17.7 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.